EFG
ABBV icon

Embree Financial Group’s AbbVie ABBV Stock Holding History

Embree Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.96M Sell
19,706
-171
-0.9% -$36.8K 0.5% 44
2026
Q1 		$4.32M Buy
19,877
+822
+4% +$182K 0.51% 43
2025
Q4 		$4.35M Buy
19,055
+382
+2% +$87K 0.53% 41
2025
Q3 		$4.32M Sell
18,673
-1,539
-8% -$313K 0.58% 37
2025
Q2 		$3.75M Buy
20,212
+524
+3% +$97.4K 0.56% 39
2025
Q1 		$4.13M Buy
19,688
+167
+0.9% +$32.5K 0.69% 30
2024
Q4 		$3.47M Buy
19,521
+43
+0.2% +$7.91K 0.59% 33
2024
Q3 		$3.85M Buy
19,478
+290
+2% +$54.1K 0.69% 29
2024
Q2 		$3.29M Sell
19,188
-1,008
-5% -$167K 0.63% 36
2024
Q1 		$3.68M Sell
20,196
-75
-0.4% -$12.9K 0.72% 28
2023
Q4 		$3.14M Buy
+20,271
New +$2.96M 0.66% 33

Other funds holding ABBV

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Embree Financial Group's ABBV Position: Q2 2026 in Review

Embree Financial Group reduced its AbbVie (ABBV) stake by 0.86% in Q2 2026, selling an estimated $36.8K and leaving 19,706 shares worth $4.96M. The position accounts for 0.5% of the portfolio, ranked #44.

Embree Financial Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Embree Financial Group held 19,706 shares of AbbVie worth $4.96M as of Q2 2026.
  • Embree Financial Group sold 171 AbbVie shares in Q2 2026, an estimated $36.8K.
  • AbbVie made up 0.5% of Embree Financial Group's portfolio in Q2 2026, its #44 holding.
  • Embree Financial Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 2,655 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.